« So you wanna get into publishing? (I) | Main | Depressing news? »

Thinking differently about schizophrenia

It's always gratifying when something you published in your journal is regarded by others as an important contribution. This report in yesterday's New York Times discusses extensively the trial we published last year showing that an agonist of metabotropic glutamate receptors was beneficial in people with schizophrenia.

It's a shame that the NYT didn't identify Nature Medicine as the place in which the original paper was published, but so be it. I'm delighted to see that the findings are receiving the attention they deserve.
largecover[2].gif

Posted by Juan Carlos Lopez on February 25, 2008 04:35 PM |

Comments

And it's so easy to include a link to the original in their online version these days. Of course, no journalist wants to do so, just in case they've completely misunderstood the point of the study, or said something bonkers. Don't want to make it too easy for the pedants with the old fashioned view that newspapers should try to be factually accurate about these things! ;)

Posted by: Joe D | March 22, 2008 10:10 AM

The article was reproduced in the media of thing happens often, but didn't identify which the original paper was published, should be a tort industry.

Posted by: 络龙医搜 | February 26, 2008 09:04 AM

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)


Please enter the numbers you see below - this helps us to cut down on spam. If you are having trouble with this system, you can instead e-mail a comment to 'medicine at natureny.com'.